Abstract
Abstract
Background/aims
Evidence from large population-based cohorts as to the association of arterial stiffness and incident chronic kidney disease (CKD) is mixed. This large population-based study aimed to investigate whether arterial stiffness, assessed oscillometrically, was associated with incident CKD.
Methods
The study population comprised 4838 participants from the Vitamin D Assessment (ViDA) Study without known CKD (mean ± SD age = 66 ± 8). Arterial stiffness was assessed from 5 April, 2011 to 6 November, 2012 by way of aortic pulse wave velocity, estimated carotid-femoral pulse wave velocity, and aortic pulse pressure. Incident CKD was determined by linkage to national hospital discharge registers. Cox proportional hazards regression was used to assess the risk of CKD in relation to chosen arterial stiffness measures over the continuum and quartiles of values.
Results
During a mean ± SD follow-up of 10.5 ± 0.4 years, 376 participants developed incident CKD. Following adjustment for potential confounders, aortic pulse wave velocity (hazard ratio (HR) per SD increase 1.69, 95% CI 1.45–1.97), estimated carotid-femoral pulse wave velocity (HR per SD increase 1.84, 95% CI 1.54–2.19), and aortic pulse pressure (HR per SD increase 1.37, 95% CI 1.22–1.53) were associated with the incidence of CKD. The risk of incident CKD was, compared to the first quartile, higher in the fourth quartile of aortic pulse wave velocity (HR 4.72, 95% CI 2.69–8.27; Ptrend < 0.001), estimated carotid-femoral pulse wave velocity (HR 4.28, 95% CI 2.45–7.50; Ptrend < 0.001) and aortic pulse pressure (HR 2.71, 95% CI 1.88–3.91; Ptrend < 0.001).
Conclusions
Arterial stiffness, as measured by aortic pulse wave velocity, estimated carotid-femoral pulse wave velocity, and aortic pulse pressure may be utilised in clinical practice to help identify people at risk of future CKD.
Trial registration
www.anzctr.org.au identifier:ACTRN12611000402943.
Graphical abstract
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR et al (2020) Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Kidney Int 97(6):1117–1129. https://doi.org/10.1016/j.kint.2020.02.010
2. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C (2019) A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Kidney Int 96(5):1048–1050. https://doi.org/10.1016/j.kint.2019.07.012
3. Kidney Health Australia (2020) Chronic kidney disease (CKD) management in primary care, 4th edn. Kidney Health Australia, Melbourne
4. Ministry of Health (2015) Managing chronic kidney disease in primary care: a national consensus statement. Ministry of Health, Wellington
5. Chirinos JA, Segers P, Hughes T, Townsend R (2019) Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol 74(9):1237–1263. https://doi.org/10.1016/j.jacc.2019.07.012